IGF::OT::IGF: Development and Testing of Virtual Reality Enhanced Dialectic Behavior Therapy (DBT) for Adolescents with Dual Diagnosis. PoP: 9/25/2017-3/24/2018. N43DA-17-5585.

IGF::OT::IGF：针对具有双重诊断的青少年的虚拟现实增强辩证行为疗法 (DBT) 的开发和测试。

• 批准号: 9583285
• 负责人: Abe Rutchick
• 金额: $ 15万
• 依托单位: APPLIEDVR, INC.
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-25 至 2018-03-24
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9583285
• 关键词: Adolescent; Comorbidity; Data; Data Security; Development; Dialectical behavior therapy; Disease; Health Insurance Portability and Accountability Act; Insurance; Mental disorders; Patients; Phase; Privacy; Reaction; Risk; Substance Use Disorder; Testing; Work; addiction; billing data; design; dual diagnosis; substance abuse treatment; task analysis; usability; virtual reality

For Phase I of the proposed project, we will conduct initial development of a virtual reality-enhanced DBT treatment for substance abuse disorders in adolescents with dual diagnoses (addiction to any substance or polysubstance use disorder and comorbid mental disorders). We will work with treatment professionals to develop appropriate VR content, engage stakeholders on the practical implications of using VR for treatment (insurance billing, data security, HIPAA privacy, etc.), determine detailed task analysis and identify potential risks through player usability testing, and collect initial qualitative data on patient and clinician reactions to the VR content.

对于拟议项目的第一阶段，我们将对具有双重诊断（对任何物质或多种物质使用障碍成瘾和共病精神障碍）的青少年药物滥用障碍进行虚拟现实增强DBT治疗的初步开发。 我们将与治疗专业人员合作开发适当的VR内容，让利益相关者参与使用VR进行治疗的实际影响（保险账单，数据安全，HIPAA隐私等），通过播放器可用性测试确定详细的任务分析并识别潜在风险，并收集患者和临床医生对VR内容反应的初步定性数据。